Filter News
Area of Research
News Topics
- (-) Biomedical (5)
- (-) Climate Change (3)
- (-) Exascale Computing (7)
- (-) Frontier (12)
- (-) Molten Salt (1)
- (-) National Security (5)
- (-) Transportation (2)
- 3-D Printing/Advanced Manufacturing (3)
- Artificial Intelligence (12)
- Big Data (1)
- Bioenergy (6)
- Biology (4)
- Biotechnology (1)
- Buildings (1)
- Chemical Sciences (3)
- Computer Science (31)
- Coronavirus (5)
- Cybersecurity (6)
- Decarbonization (1)
- Energy Storage (5)
- Environment (3)
- Grid (3)
- High-Performance Computing (11)
- Isotopes (1)
- Machine Learning (5)
- Materials (8)
- Materials Science (6)
- Microscopy (5)
- Nanotechnology (5)
- Neutron Science (7)
- Nuclear Energy (1)
- Partnerships (1)
- Physics (4)
- Quantum Computing (5)
- Quantum Science (10)
- Security (4)
- Simulation (1)
- Space Exploration (1)
- Summit (14)
- Sustainable Energy (5)
Media Contacts
Six ORNL scientists have been elected as fellows to the American Association for the Advancement of Science, or AAAS.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
Gina Tourassi has been appointed as director of the National Center for Computational Sciences, a division of the Computing and Computational Sciences Directorate at Oak Ridge National Laboratory.
OAK RIDGE, Tenn., May 7, 2019—The U.S. Department of Energy today announced a contract with Cray Inc. to build the Frontier supercomputer at Oak Ridge National Laboratory, which is anticipated to debut in 2021 as the world’s most powerful computer with a performance of greater than 1.5 exaflops.
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.